MIMETAS
@mimetas.bsky.social
We strive to contribute to groundbreaking therapies with our screenable, physiologically relevant 3D human disease models.
🎓 Congrats to Dr. Murillo Bernardi on his successful PhD defense! His thesis, “From Chick to Chip - Novel models to bridge in vitro and in vivo kidney research” presents years of work on advancing predictive kidney models at UMC Utrecht and MIMETAS.
#PhDDefense #MIMETAS
#PhDDefense #MIMETAS
November 13, 2025 at 3:26 PM
🎓 Congrats to Dr. Murillo Bernardi on his successful PhD defense! His thesis, “From Chick to Chip - Novel models to bridge in vitro and in vivo kidney research” presents years of work on advancing predictive kidney models at UMC Utrecht and MIMETAS.
#PhDDefense #MIMETAS
#PhDDefense #MIMETAS
In this app note, learn how MIMETAS’ OrganoReady® Blood Vessel models enable high-throughput, human-relevant toxicity screening in 3D microfluidic blood vessel systems. Ultimately, this supports the development of safer therapeutics and better treatment strategies.
🔗 shorturl.at/gtn5M
🔗 shorturl.at/gtn5M
November 11, 2025 at 2:42 PM
In this app note, learn how MIMETAS’ OrganoReady® Blood Vessel models enable high-throughput, human-relevant toxicity screening in 3D microfluidic blood vessel systems. Ultimately, this supports the development of safer therapeutics and better treatment strategies.
🔗 shorturl.at/gtn5M
🔗 shorturl.at/gtn5M
New publication from BIOASTER! Using the OrganoPlate® platform and OrganoTEER® device, they built an immunocompetent intestinal model showing that Bifidobacterium infantis and Lacticaseibacillus rhamnosus GG protect the gut barrier from inflammation. www.mdpi.com/2673-8007/5/...
November 5, 2025 at 3:38 PM
New publication from BIOASTER! Using the OrganoPlate® platform and OrganoTEER® device, they built an immunocompetent intestinal model showing that Bifidobacterium infantis and Lacticaseibacillus rhamnosus GG protect the gut barrier from inflammation. www.mdpi.com/2673-8007/5/...
⏰ Last chance! Join us tomorrow for our webinar on Ready-to-Use Colon Organoids for Multimodal Toxicity Assessment.
• Quantify transporter expression & function
• Gain morphological insights via Spark® Cyto imaging
• Scale workflows for reproducible preclinical evaluation
🔗 lnkd.in/eGXKeYCn
• Quantify transporter expression & function
• Gain morphological insights via Spark® Cyto imaging
• Scale workflows for reproducible preclinical evaluation
🔗 lnkd.in/eGXKeYCn
November 3, 2025 at 2:12 PM
⏰ Last chance! Join us tomorrow for our webinar on Ready-to-Use Colon Organoids for Multimodal Toxicity Assessment.
• Quantify transporter expression & function
• Gain morphological insights via Spark® Cyto imaging
• Scale workflows for reproducible preclinical evaluation
🔗 lnkd.in/eGXKeYCn
• Quantify transporter expression & function
• Gain morphological insights via Spark® Cyto imaging
• Scale workflows for reproducible preclinical evaluation
🔗 lnkd.in/eGXKeYCn
Something big is coming.
A new way to explore and experience MIMETAS' innovation.
Stay tuned. 👀
A new way to explore and experience MIMETAS' innovation.
Stay tuned. 👀
October 31, 2025 at 3:16 PM
Something big is coming.
A new way to explore and experience MIMETAS' innovation.
Stay tuned. 👀
A new way to explore and experience MIMETAS' innovation.
Stay tuned. 👀
🗓️ Only 1 week to go!
Join our live webinar to learn how physiologically relevant gut organoid models, combined with advanced readout platforms, can elevate the predictive power of preclinical research.
Register now: shorturl.at/Qws5a
#Organoids #PreclinicalResearch
Join our live webinar to learn how physiologically relevant gut organoid models, combined with advanced readout platforms, can elevate the predictive power of preclinical research.
Register now: shorturl.at/Qws5a
#Organoids #PreclinicalResearch
October 28, 2025 at 3:17 PM
🗓️ Only 1 week to go!
Join our live webinar to learn how physiologically relevant gut organoid models, combined with advanced readout platforms, can elevate the predictive power of preclinical research.
Register now: shorturl.at/Qws5a
#Organoids #PreclinicalResearch
Join our live webinar to learn how physiologically relevant gut organoid models, combined with advanced readout platforms, can elevate the predictive power of preclinical research.
Register now: shorturl.at/Qws5a
#Organoids #PreclinicalResearch
🎓 Congratulations to Dr. Bart Kramer!
Our Scientific Project Lead has successfully defended his PhD on “Vasculature and Flow in Microfluidic Systems.”
His work advances organ-on-a-chip models by bringing vascular flow closer to real human biology. 👏
#OrganOnAChip #PhD
Our Scientific Project Lead has successfully defended his PhD on “Vasculature and Flow in Microfluidic Systems.”
His work advances organ-on-a-chip models by bringing vascular flow closer to real human biology. 👏
#OrganOnAChip #PhD
October 24, 2025 at 12:42 PM
🎓 Congratulations to Dr. Bart Kramer!
Our Scientific Project Lead has successfully defended his PhD on “Vasculature and Flow in Microfluidic Systems.”
His work advances organ-on-a-chip models by bringing vascular flow closer to real human biology. 👏
#OrganOnAChip #PhD
Our Scientific Project Lead has successfully defended his PhD on “Vasculature and Flow in Microfluidic Systems.”
His work advances organ-on-a-chip models by bringing vascular flow closer to real human biology. 👏
#OrganOnAChip #PhD
Our Territory Manager, Nick Saites is at #NAVBO2025 in Cape Cod! He presented on:
🧬 Perfusable vascular networks using a gravity-driven microfluidic system
🧠 High-throughput BBB-on-a-chip model for drug discovery
Download the poster: shorturl.at/PToVa
🧬 Perfusable vascular networks using a gravity-driven microfluidic system
🧠 High-throughput BBB-on-a-chip model for drug discovery
Download the poster: shorturl.at/PToVa
October 22, 2025 at 2:18 PM
Our Territory Manager, Nick Saites is at #NAVBO2025 in Cape Cod! He presented on:
🧬 Perfusable vascular networks using a gravity-driven microfluidic system
🧠 High-throughput BBB-on-a-chip model for drug discovery
Download the poster: shorturl.at/PToVa
🧬 Perfusable vascular networks using a gravity-driven microfluidic system
🧠 High-throughput BBB-on-a-chip model for drug discovery
Download the poster: shorturl.at/PToVa
Yesterday, we welcomed visitors from GemeenteLeiden, LeidenBSP, and NBTC - part of the #NewDutch network - to MIMETAS!
The visit spotlighted Dutch innovation in cancer research, with lab tours showcasing how our Organ-on-a-Chip tech accelerates better therapies.
The visit spotlighted Dutch innovation in cancer research, with lab tours showcasing how our Organ-on-a-Chip tech accelerates better therapies.
October 16, 2025 at 12:17 PM
Yesterday, we welcomed visitors from GemeenteLeiden, LeidenBSP, and NBTC - part of the #NewDutch network - to MIMETAS!
The visit spotlighted Dutch innovation in cancer research, with lab tours showcasing how our Organ-on-a-Chip tech accelerates better therapies.
The visit spotlighted Dutch innovation in cancer research, with lab tours showcasing how our Organ-on-a-Chip tech accelerates better therapies.
Traditional in vitro models can’t fully capture human gut complexity. Join Christian Oberdanner (Tecan) & Sara Shafiei (MIMETAS) for a live webinar on Nov 4 to explore how gut organoid models + advanced readouts are redefining preclinical research. Register now: shorturl.at/Qws5a
October 16, 2025 at 7:56 AM
Traditional in vitro models can’t fully capture human gut complexity. Join Christian Oberdanner (Tecan) & Sara Shafiei (MIMETAS) for a live webinar on Nov 4 to explore how gut organoid models + advanced readouts are redefining preclinical research. Register now: shorturl.at/Qws5a
Our Early Stage Researcher Tomás Coimbra is at FIGON Dutch Medicines Days (Oct 8–9)! ✨
He’s presenting:
“A scalable human primary liver model to study cell-cell interactions.”
📍 Poster sessions: 12:30–14:00, both days.
Don’t miss it if you’re attending!
He’s presenting:
“A scalable human primary liver model to study cell-cell interactions.”
📍 Poster sessions: 12:30–14:00, both days.
Don’t miss it if you’re attending!
October 8, 2025 at 1:37 PM
Our Early Stage Researcher Tomás Coimbra is at FIGON Dutch Medicines Days (Oct 8–9)! ✨
He’s presenting:
“A scalable human primary liver model to study cell-cell interactions.”
📍 Poster sessions: 12:30–14:00, both days.
Don’t miss it if you’re attending!
He’s presenting:
“A scalable human primary liver model to study cell-cell interactions.”
📍 Poster sessions: 12:30–14:00, both days.
Don’t miss it if you’re attending!
In this customer publication, researchers used MIMETAS’ OrganoReady® Colon Organoid and OrganoTEER® to show how a Lactobacillaceae-derived postbiotic protects the gut barrier, supports recovery, and reduces inflammation. Read it here: www.mdpi.com/2304-8158/14...
www.mdpi.com
October 7, 2025 at 2:08 PM
In this customer publication, researchers used MIMETAS’ OrganoReady® Colon Organoid and OrganoTEER® to show how a Lactobacillaceae-derived postbiotic protects the gut barrier, supports recovery, and reduces inflammation. Read it here: www.mdpi.com/2304-8158/14...
GI toxicity is a major side effect of cancer therapies. Our 3D Colon Organoid Model brings human relevance + high-throughput screening to better predict drug-induced GI toxicity. Explore our poster 👉 shorturl.at/8APaR #Toxicology #Organoids #DrugDevelopment #Innovation
September 29, 2025 at 12:55 PM
GI toxicity is a major side effect of cancer therapies. Our 3D Colon Organoid Model brings human relevance + high-throughput screening to better predict drug-induced GI toxicity. Explore our poster 👉 shorturl.at/8APaR #Toxicology #Organoids #DrugDevelopment #Innovation
📸 Proud moment! Our VP of Biology, Henriette Lanz, presented at #GoodbyeFlatBiology. She shared insight on using patient-derived 3D tumor models to support cell therapy programs by replicating the complex tumor-microenvironment in vitro.
#OrgansOnChips #FutureOfBiology
#OrgansOnChips #FutureOfBiology
September 25, 2025 at 12:34 PM
📸 Proud moment! Our VP of Biology, Henriette Lanz, presented at #GoodbyeFlatBiology. She shared insight on using patient-derived 3D tumor models to support cell therapy programs by replicating the complex tumor-microenvironment in vitro.
#OrgansOnChips #FutureOfBiology
#OrgansOnChips #FutureOfBiology
🔬Today on #WorldCancerResearchDay, we recognize the need for research that leads to better cancer treatments and outcomes.
At MIMETAS, we support scientists with human relevant 3D models that improve translation from lab to clinic.
At MIMETAS, we support scientists with human relevant 3D models that improve translation from lab to clinic.
September 24, 2025 at 12:29 PM
🔬Today on #WorldCancerResearchDay, we recognize the need for research that leads to better cancer treatments and outcomes.
At MIMETAS, we support scientists with human relevant 3D models that improve translation from lab to clinic.
At MIMETAS, we support scientists with human relevant 3D models that improve translation from lab to clinic.
🚨 #EuroTox Day 2! Meet MIMETAS’ Brian Duggan & Debarati Shome as they present two posters on Risk Prediction and Assessment using NAMs and An Assay-Ready ASC-Derived Colon Organoid Model for Evaluating Therapy-Induced Gastrointestinal Toxicity. Join the sessions or connect with our experts!
September 16, 2025 at 10:05 AM
🚨 #EuroTox Day 2! Meet MIMETAS’ Brian Duggan & Debarati Shome as they present two posters on Risk Prediction and Assessment using NAMs and An Assay-Ready ASC-Derived Colon Organoid Model for Evaluating Therapy-Induced Gastrointestinal Toxicity. Join the sessions or connect with our experts!
📢 New customer publication! Researchers used our OrganoPlate® platform to develop a Glomerulus-on-a-Chip to show vincristine protects podocytes in FSGS, a major kidney disease. First evidence of its protective effect! Read the publication: www.sciencedirect.com/science/arti...
September 12, 2025 at 11:38 AM
📢 New customer publication! Researchers used our OrganoPlate® platform to develop a Glomerulus-on-a-Chip to show vincristine protects podocytes in FSGS, a major kidney disease. First evidence of its protective effect! Read the publication: www.sciencedirect.com/science/arti...
Meet MIMETAS at #EUROTOX2025 in Athens, Sept 14–17! Connect with our experts Debarati Shome & Brian Duggan to explore our latest 3D human tissue models for toxicity research. Don’t miss our posters on Sept 15 & 16! 🔗 eurotox2025.com #Toxicology #DrugSafety
September 10, 2025 at 1:56 PM
Meet MIMETAS at #EUROTOX2025 in Athens, Sept 14–17! Connect with our experts Debarati Shome & Brian Duggan to explore our latest 3D human tissue models for toxicity research. Don’t miss our posters on Sept 15 & 16! 🔗 eurotox2025.com #Toxicology #DrugSafety
Team spirit on the canals! 🚤 Our MIMETAS crew competed in a boating challenge through Leiden, celebrated the winners 🏆, and wrapped it up with a cozy dinner together for our annual company outing. A day of laughter, teamwork & connection!
September 10, 2025 at 8:19 AM
Team spirit on the canals! 🚤 Our MIMETAS crew competed in a boating challenge through Leiden, celebrated the winners 🏆, and wrapped it up with a cozy dinner together for our annual company outing. A day of laughter, teamwork & connection!
At MIMETAS, growth is personal. Marketing Specialist Chiwan Chiang shares how curiosity, creativity, and stepping outside your comfort zone shape a career—and a company.
💬 “When you think you have failed, you’ve only gained knowledge.”
Full interview: shorturl.at/hBbyY
💬 “When you think you have failed, you’ve only gained knowledge.”
Full interview: shorturl.at/hBbyY
September 4, 2025 at 1:51 PM
At MIMETAS, growth is personal. Marketing Specialist Chiwan Chiang shares how curiosity, creativity, and stepping outside your comfort zone shape a career—and a company.
💬 “When you think you have failed, you’ve only gained knowledge.”
Full interview: shorturl.at/hBbyY
💬 “When you think you have failed, you’ve only gained knowledge.”
Full interview: shorturl.at/hBbyY
How do you model lungs more realistically? 🌬️ Find out in our Sept 9 webinar. Register: shorturl.at/8Es4r #OrganonaChip #LungResearch #LungModels
September 2, 2025 at 2:11 PM
How do you model lungs more realistically? 🌬️ Find out in our Sept 9 webinar. Register: shorturl.at/8Es4r #OrganonaChip #LungResearch #LungModels
🧠 New study from MIMETAS & Roche (pRED) shows how the ApoE4 Alzheimer’s risk gene alters brain endothelial function & iron transport.
Using our iPSC-based BBB model + Roche’s BrainShuttle tech, we uncovered ApoE4-driven changes that may shape how therapies can reach the brain. shorturl.at/RwgUP
Using our iPSC-based BBB model + Roche’s BrainShuttle tech, we uncovered ApoE4-driven changes that may shape how therapies can reach the brain. shorturl.at/RwgUP
August 27, 2025 at 2:28 PM
🧠 New study from MIMETAS & Roche (pRED) shows how the ApoE4 Alzheimer’s risk gene alters brain endothelial function & iron transport.
Using our iPSC-based BBB model + Roche’s BrainShuttle tech, we uncovered ApoE4-driven changes that may shape how therapies can reach the brain. shorturl.at/RwgUP
Using our iPSC-based BBB model + Roche’s BrainShuttle tech, we uncovered ApoE4-driven changes that may shape how therapies can reach the brain. shorturl.at/RwgUP
In this app note, read about a high-throughput 3D human BBB model that has:
🔹 Human-relevant barrier physiology
🔹 Tight junctions & transporter expression
🔹 Predictable response to compounds
🔹 High-throughput with 40–64 perfused chips
shorturl.at/ire7v
🔹 Human-relevant barrier physiology
🔹 Tight junctions & transporter expression
🔹 Predictable response to compounds
🔹 High-throughput with 40–64 perfused chips
shorturl.at/ire7v
August 21, 2025 at 2:33 PM
In this app note, read about a high-throughput 3D human BBB model that has:
🔹 Human-relevant barrier physiology
🔹 Tight junctions & transporter expression
🔹 Predictable response to compounds
🔹 High-throughput with 40–64 perfused chips
shorturl.at/ire7v
🔹 Human-relevant barrier physiology
🔹 Tight junctions & transporter expression
🔹 Predictable response to compounds
🔹 High-throughput with 40–64 perfused chips
shorturl.at/ire7v
In our latest The ‘I’ in MIMETAS feature, Product Design Engineer Frederik Schavemaker shares how intuition, curiosity, and design come together to bring tools like OrganoTEER® to life.
👉 Meet the people behind the biology: shorturl.at/yUp6q
#TheIinMIMETAS #ProductDesign #OrganOnChip
👉 Meet the people behind the biology: shorturl.at/yUp6q
#TheIinMIMETAS #ProductDesign #OrganOnChip
August 19, 2025 at 2:12 PM
In our latest The ‘I’ in MIMETAS feature, Product Design Engineer Frederik Schavemaker shares how intuition, curiosity, and design come together to bring tools like OrganoTEER® to life.
👉 Meet the people behind the biology: shorturl.at/yUp6q
#TheIinMIMETAS #ProductDesign #OrganOnChip
👉 Meet the people behind the biology: shorturl.at/yUp6q
#TheIinMIMETAS #ProductDesign #OrganOnChip
MIMETAS' Oncology Services help pharma accelerate cancer drug discovery with 3D tumor models that truly mimic human biology. From CAR T cell assays to large-scale screening, we deliver predictive insights for faster, targeted therapies.
🔗 Explore: shorturl.at/fnWTA
#Oncology #DrugDiscovery
🔗 Explore: shorturl.at/fnWTA
#Oncology #DrugDiscovery
August 13, 2025 at 1:18 PM
MIMETAS' Oncology Services help pharma accelerate cancer drug discovery with 3D tumor models that truly mimic human biology. From CAR T cell assays to large-scale screening, we deliver predictive insights for faster, targeted therapies.
🔗 Explore: shorturl.at/fnWTA
#Oncology #DrugDiscovery
🔗 Explore: shorturl.at/fnWTA
#Oncology #DrugDiscovery